Postinflammatory Papule: A Tentative New Designation for Acne Vulgaris Toshitatsu NogitaYuko NomuraIchiro Kurokawa Commentary Open access 16 October 2021 Pages: 1867 - 1869
Dermoscopy in General Dermatology (Non-Neoplastic Dermatoses): The Journey So Far Enzo Errichetti Commentary Open access 19 October 2021 Pages: 1871 - 1877
Light-Based Devices for the Treatment of Facial Erythema and Telangiectasia Vani YepuriAnant D. PatilMohamad Goldust Review Open access 25 September 2021 Pages: 1879 - 1887
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy Federico DiotalleviAnna CampanatiAnnamaria Offidani Review Open access 29 September 2021 Pages: 1889 - 1903
Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties Jaime Piquero-CasalsDaniel Morgado-CarrascoJean Krutmann Review Open access 01 October 2021 Pages: 1905 - 1915
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options Alan MenterAbby S. Van VoorheesSylvia Hsu Review Open access 09 October 2021 Pages: 1917 - 1929
A Comprehensive Update of the Atypical, Rare and Mimicking Presentations of Mycosis Fungoides Eve LebasPatrick CollinsArjen F. Nikkels Review Open access 28 October 2021 Pages: 1931 - 1951
Clinical Features and Risk Factors for Nasal Rosacea: A Hospital-Based Retrospective Study Ai-ke WuFang-fen LiuJi Li Original Research Open access 04 September 2021 Pages: 1953 - 1963
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Kyle FahrbachGrammati SarriKristian Reich Original Research Open access 22 September 2021 Pages: 1965 - 1998
Skin-Disease Specific and Generic Psychometric Measures in Patients with Psoriasis Beata KowalewskaBarbara JankowiakMarek Sobolewski Original Research Open access 28 September 2021 Pages: 1999 - 2015
Quality of Life of Infants, Toddlers and Preschoolers with Seborrhoeic, Allergic Contact and Atopic Dermatitis Before and During COVID-19 Pandemic Pavel V. ChernyshovSvitlana V. VozianovaOlga V. Chubar Original Research Open access 25 September 2021 Pages: 2017 - 2026
Increased Skin Clearance and Quality of Life Improvement with Brodalumab Compared with Ustekinumab in Psoriasis Patients with Aggravating Lifestyle Factors Georgios KokolakisKasper VadstrupJose Manuel Carrascosa Original Research Open access 02 October 2021 Pages: 2027 - 2042
Modulation of Photoaging-Induced Cutaneous Elastin: Evaluation of Gene and Protein Expression of Markers Related to Elastogenesis Under Different Photoexposure Conditions Ana Cristina WeihermannCamila Miranda de CarvalhoCarla Abdo Brohem Original Research Open access 14 October 2021 Pages: 2043 - 2056
Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals Shaloo GuptaSteven GarbariniDavid Kaplan Original Research Open access 14 October 2021 Pages: 2057 - 2075
Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS) Steven R. FeldmanMorten PræstegaardTove Holm-Larsen Original Research Open access 14 October 2021 Pages: 2077 - 2088
Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis Ru DaiBingJiang LinSuling Xu Original Research Open access 18 October 2021 Pages: 2089 - 2105
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study Marcus Schmitt-EgenolfJonatan FreilichLars-Åke Levin Original Research Open access 14 October 2021 Pages: 2107 - 2121
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective Marjolein de Bruin-WellerJoseph F. MerolaAna B. Rossi Original Research Open access 12 November 2021 Pages: 2123 - 2131
Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months Andrew BlauveltNianwen ShiMwangi J. Murage Original Research Open access 15 October 2021 Pages: 2133 - 2145
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis Gil YosipovitchMarjolein de Bruin-WellerJingdong Chao Original Research Open access 29 October 2021 Pages: 2147 - 2157
Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada Mahreen AmeenStephan Meller(the BADEL Study Group) Original Research Open access 26 October 2021 Pages: 2159 - 2177
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis Robert BissonnetteCatherine MaariNihar Bhakta Original Research Open access 30 October 2021 Pages: 2179 - 2193
Prospective, Randomized, Double-Blind, Placebo-Controlled Study on Efficacy of Copaiba Oil in Silicone-Based Gel to Reduce Scar Formation Jill WaibelHarshad PatelRodrigo Lupatini Original Research Open access 23 October 2021 Pages: 2195 - 2205
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain Esteban DaudénGlauber Pacelli Gomes de LimaMar Llamas-Velasco Brief Report Open access 24 September 2021 Pages: 2207 - 2215
Electrocardiogram Findings in Patients with Alopecia Areata Danielle PetersonCarlos WambierBrett King Brief Report Open access 26 September 2021 Pages: 2217 - 2223
Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial Karl LewisReinhard DummerMichael Migden Brief Report Open access 20 October 2021 Pages: 2225 - 2234
A Case of Erythema Elevatum Diutinum (EED) Exhibiting A Keloid-Like Appearance Bint-e AwanYoshihiro NodaRei Ogawa Case Report Open access 14 November 2021 Pages: 2235 - 2240
Response to the Letter to the Editor Regarding “Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systemic Literature Review and Network Meta-Analysis” Kyle FahrbachJialu TarpeyJoseph C. Cappelleri Letter Open access 10 October 2021 Pages: 2241 - 2244
Letter to the Editor Regarding ‘An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-Vesicular Emulsion in People with Dry, Eczema-Prone Skin: The RESTORE Study Phase 1’ Anthony Vincent RawlingsMajella E. Lane Letter Open access 17 October 2021 Pages: 2245 - 2248
Response to: Letter to the Editor Regarding “An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-Vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1” Simon G. DanbyPaul V. AndrewMichael J. Cork Letter Open access 18 October 2021 Pages: 2249 - 2252